With reference to its intimation letter dated November 11, 2024 under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Indrayani Biotech has informed that at the meeting of Board of Directors held on Thursday, November 14, 2024, the Directors have approved the following: Unaudited Financial Results (Standalone and Consolidated) with the Limited Review Report for the quarter and half year ended September 30, 2024 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements} Regulations, 2015. The statutory auditors have reviewed the financial results and given unmodified opinion. (Results are provided as Annexure). The necessary arrangements are in place to publish the unaudited financial results in the newspapers. The said financial results will also be available on company’s website www.indrayani.com and also on BSE website www.bseindia.com. The Board has considered the issue of fully paid-up equity shares by way of a rights issue to the existing shareholders of the Company in accordance with the provisions of Companies Act, 2013 and the rules made thereunder, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws for an amount not exceeding Rs.49.90 Crores. iii. Further, the Board has constituted a Rights Issue Committee and authorized its members to decide on the terms and conditions of the Issue, including but not limited to, the final Issue size/amount, rights entitlement ratio, the issue price, record date, timing of the Rights Issue, approval of draft letter of offer; appointment of intermediaries, if required; allotment of shares and other related matters. The meeting commenced at 03:00 pm and concluded at 11:40 pm.
| Company Name | CMP |
|---|---|
| Indrayani Biotech | 42.37 |
| SIP Industries | 6.01 |
| Trescon | 15.90 |
| Jayasilpa Floritech | |
| Farmtek Agro Exports | |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
